ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 195 filers reported holding ANI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +33.3% | 70 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.7% | 70 | +159.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 27 | -60.3% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 68 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 68 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 68 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | -33.3% | 68 | -10.5% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | +20.0% | 76 | +18.8% | 0.00% | – |
| Q1 2019 | $5,000 | +66.7% | 64 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 64 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | 0.0% | 64 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 64 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |